Brainstorm Cell Therapeutics reported $25.79M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US 30.55M 7.75M
Biogen BIIB:US $ 23614.4M 262.9M
Brainstorm Cell Therapeutics BCLI:US $ 25.79M 3.49M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Cytokinetics CYTK:US $ 856.25M 14.93M
Gilead Sciences GILD:US $ 63080M 4872M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Idera Pharmaceuticals IDRA:US $ 30.13M 4.73M